These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37695134)
1. Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial. Castilla-Ojo N; Turkson-Ocran RA; Conlin PR; Appel LJ; Miller ER; Juraschek SP J Clin Hypertens (Greenwich); 2023 Oct; 25(10):915-922. PubMed ID: 37695134 [TBL] [Abstract][Full Text] [Related]
2. Effects of Dietary Patterns on Serum Urate: Results From a Randomized Trial of the Effects of Diet on Hypertension. Juraschek SP; Yokose C; McCormick N; Miller ER; Appel LJ; Choi HK Arthritis Rheumatol; 2021 Jun; 73(6):1014-1020. PubMed ID: 33615722 [TBL] [Abstract][Full Text] [Related]
3. Effects of dietary macronutrients on serum urate: results from the OmniHeart trial. Belanger MJ; Wee CC; Mukamal KJ; Miller ER; Sacks FM; Appel LJ; Shmerling RH; Choi HK; Juraschek SP Am J Clin Nutr; 2021 Jun; 113(6):1593-1599. PubMed ID: 33668058 [TBL] [Abstract][Full Text] [Related]
4. A Randomized Pilot Study of DASH Patterned Groceries on Serum Urate in Individuals with Gout. Juraschek SP; Miller ER; Wu B; White K; Charleston J; Gelber AC; Rai SK; Carson KA; Appel LJ; Choi HK Nutrients; 2021 Feb; 13(2):. PubMed ID: 33562216 [TBL] [Abstract][Full Text] [Related]
5. Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid. Juraschek SP; Gelber AC; Choi HK; Appel LJ; Miller ER Arthritis Rheumatol; 2016 Dec; 68(12):3002-3009. PubMed ID: 27523583 [TBL] [Abstract][Full Text] [Related]
6. Effects of a Dietary Approach to Stop Hypertension (DASH) Diet Intervention on Serum Uric Acid in African Americans With Hypertension. Juraschek SP; White K; Tang O; Yeh HC; Cooper LA; Miller ER Arthritis Care Res (Hoboken); 2018 Oct; 70(10):1509-1516. PubMed ID: 29342506 [TBL] [Abstract][Full Text] [Related]
7. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis. Perez-Ruiz F; Herrero-Beites AM; Carmona L Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351 [TBL] [Abstract][Full Text] [Related]
8. Adherence to the Dietary Approaches to Stop Hypertension (DASH) and Serum Urate Concentrations: A Longitudinal Analysis from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Fajardo VC; Barreto SM; Coelho CG; Diniz MFH; Molina MDCB; Ribeiro ALP; Telles RW J Nutr; 2024 Jan; 154(1):133-142. PubMed ID: 37992809 [TBL] [Abstract][Full Text] [Related]
9. DASH diet and change in serum uric acid over time. Tang O; Miller ER; Gelber AC; Choi HK; Appel LJ; Juraschek SP Clin Rheumatol; 2017 Jun; 36(6):1413-1417. PubMed ID: 28361235 [TBL] [Abstract][Full Text] [Related]
10. The DASH diet enhances the blood pressure response to losartan in hypertensive patients. Conlin PR; Erlinger TP; Bohannon A; Miller ER; Appel LJ; Svetkey LP; Moore TJ Am J Hypertens; 2003 May; 16(5 Pt 1):337-42. PubMed ID: 12745193 [TBL] [Abstract][Full Text] [Related]
11. The effect of dietary approaches to stop hypertension and ketogenic diets intervention on serum uric acid concentration: a systematic review and meta-analysis of randomized controlled trials. Gohari S; Ghobadi S; Jafari A; Ahangar H; Gohari S; Mahjani M Sci Rep; 2023 Jun; 13(1):10492. PubMed ID: 37380733 [TBL] [Abstract][Full Text] [Related]
12. Adherence to the Dietary Approaches to Stop Hypertension Diet and Hyperuricemia: A Cross-Sectional Study. Gao Y; Cui LF; Sun YY; Yang WH; Wang JR; Wu SL; Gao X Arthritis Care Res (Hoboken); 2021 Apr; 73(4):603-611. PubMed ID: 31961500 [TBL] [Abstract][Full Text] [Related]
13. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study. Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979 [TBL] [Abstract][Full Text] [Related]
14. Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial. Mu Z; Wang W; Wang J; Lv W; Chen Y; Wang F; Yu X; Wang Y; Cheng B; Wang Z Clin Rheumatol; 2019 Dec; 38(12):3511-3519. PubMed ID: 31410659 [TBL] [Abstract][Full Text] [Related]
15. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369 [TBL] [Abstract][Full Text] [Related]
16. Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure. Juraschek SP; Miller ER; Weaver CM; Appel LJ J Am Coll Cardiol; 2017 Dec; 70(23):2841-2848. PubMed ID: 29141784 [TBL] [Abstract][Full Text] [Related]
17. Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial. Tanaka A; Taguchi I; Teragawa H; Ishizaka N; Kanzaki Y; Tomiyama H; Sata M; Sezai A; Eguchi K; Kato T; Toyoda S; Ishibashi R; Kario K; Ishizu T; Ueda S; Maemura K; Higashi Y; Yamada H; Ohishi M; Yokote K; Murohara T; Oyama JI; Node K; PLoS Med; 2020 Apr; 17(4):e1003095. PubMed ID: 32320401 [TBL] [Abstract][Full Text] [Related]
18. The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale. Saddekni MB; Saag KG; Dudenbostel T; Oparil S; Calhoun DA; Sattui SE; Feig DI; Muntner P; Redden DT; Foster PJ; Rahn EJ; Biggers SR; Li P; Gaffo AL Contemp Clin Trials; 2016 Sep; 50():238-44. PubMed ID: 27587282 [TBL] [Abstract][Full Text] [Related]
19. Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients. Hamada T; Mizuta E; Kondo T; Hirai M; Yamada K; Kato M; Shigemasa C; Yamamoto Y; Ninomiya H; Igawa O; Hisatome I Arzneimittelforschung; 2010; 60(2):71-5. PubMed ID: 20329654 [TBL] [Abstract][Full Text] [Related]